by Molecular Therapy
Scientists have developed a model to assess the efficacy of mRNA-based chimeric antigen receptor (CAR) T cells, which are understudied despite their potential in treating glioblastoma (GBM) and...
by Blood
Innate lymphoid cells (ILCs) derived from hematopoietic stem cells mitigate graft-versus-host disease (GVHD) in human and mice models but, until now, how they do so has not been fully understood.
by Blood Advances
A real-world study affirmed the safety and efficacy of belumosudil in patients with chronic graft-versus-host disease (cGVHD) while also comparing its performance relative to best available...
by Transplantation and Cellular Therapy - The Official Journal of ASTCT
Retrospective data suggest concerns typically associated with HLA-DQB1-mismatched donors in hematopoietic cell transplantation (HCT) may not be relevant in the context of post-transplantation...
by Oncology On the Go and ASTCT Talks
by ASTCT Talks
In this episode of ASTCT Talks, Dr. Taha Al-Juhaishi is joined by Dr. Filippo Milano, director of the Cord Blood Transplant Program at Fred Hutch, for a wide-ranging conversation on the...